cushieblog.com
Drug trial begins for Cushing’s syndrome therapy
Participant enrollment has concluded for a phase 3 trial investigating the safety and efficacy of levoketoconazole, a cortisol synthesis inhibitor, for the treatment of endogenous Cushing’s syndrom…